Skip to content
HowShorted

Sorrento Therapeutics, Inc. short interest in 2021

In 2021, Sorrento Therapeutics, Inc.'s disclosed short interest ran from 26.80% of shares outstanding on 15 Jan 2021 to 14.00% on 31 Dec 2021, a change of -12.80 percentage points. The year's high was 26.80% on 15 Jan 2021 and its low 14.00% on 31 Dec 2021, averaging 17.78% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.36 days on 28 May 2021. Full history: Sorrento Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Sorrento Therapeutics, Inc. in 2021

2021 in figures

Start of year
26.80% (15 Jan 2021)
End of year
14.00% (31 Dec 2021)
Change
-12.80 pp
High
26.80% (15 Jan 2021)
Low
14.00% (31 Dec 2021)
Average
17.78%
Highest days to cover
12.36 (28 May 2021)
SEC filings marked
4

Every report in 2021

Sorrento Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202126.80%7.80
29 Jan 202122.83%1.90
12 Feb 202122.88%3.15
26 Feb 202120.31%4.7910-K filed
15 Mar 202120.00%4.66
31 Mar 202119.97%7.17
15 Apr 202121.24%7.36
30 Apr 202119.75%7.92
14 May 202118.64%9.1510-Q filed
28 May 202117.67%12.36
15 Jun 202117.73%6.02
30 Jun 202117.57%6.72
15 Jul 202116.86%4.96
30 Jul 202116.24%10.73
13 Aug 202115.65%9.6410-Q filed
31 Aug 202114.52%8.68
15 Sep 202114.45%10.01
30 Sep 202115.32%10.16
15 Oct 202115.44%8.61
29 Oct 202114.89%10.87
15 Nov 202114.79%9.2810-Q filed
30 Nov 202114.81%8.72
15 Dec 202114.41%6.63
31 Dec 202114.00%6.35

See also: Sorrento Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.